This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Advanced Reporting Package Helps Drive Improvement At Home Health Agencies

LINCOLN, Neb., Aug. 22, 2013 (GLOBE NEWSWIRE) -- National Research Corporation is proud to announce the launch of Hospitalization Insights, a package of reports and dashboards that inform home health agencies about hospitalization rates, performance relative to their peers, and key opportunities for improvement. Understanding hospitalization metrics helps agencies enhance the patient experience, improve population health, and control healthcare costs. These key components of the product align with the mandates of the Affordable Care Act, including lowering costs by improving care across the continuum and providing a person-centered approach. Today's healthcare environment involves more hospitals and systems partnering with home health agencies in order to adopt optimal hospitalization management strategies. Jason Stevens, Vice President of Post-Acute Care at National Research, said the focus of hospitalization rates continues to increase throughout all of healthcare. "The Hospitalization Insights solution offers the level of data home health agencies need to spot opportunities for improvement, but also provide reports that will demonstrate your value as a care coordination partner to hospitals and other referral sources," Stevens said. Several benefits of the reports include real-time data focusing on the 30-day readmission rate and 60-day claims based Medicare admission rates, a patient risk assessment that provides statistics on potential hospitalization upon admission, and analysis reporting that showcases improvement opportunities. Learn more about the benefits. To learn more about Hospitalization Insights, to receive a demo, or to access a recording of a webinar on this topic contact National Research at About National Research Corporation

For more than 30 years, National Research Corporation (NASDAQ: NRCIA|NRCIB) has been at the forefront of patient-centered care. Today, the company's focus on empowering customer-centric healthcare across the continuum extends patient-centered care to incorporate families, communities, employees, senior housing residents, and other stakeholders. Clinical outcomes and analytics solutions from National Research help identify a path to better quality outcomes and patient experiences for home health agencies. Recognized by Modern Healthcare as one of the largest patient satisfaction firms in the U.S., National Research is dedicated to representing the true voice of patients and other healthcare stakeholders. This integration of cross-continuum metrics and analytics uncovers insights for effective performance improvement, quality measurement, care transitions, and many other factors that impact population health management. National Research is headquartered in Lincoln, Nebraska. For more information, call 800-388-4264, write to, or visit .
CONTACT: Scott Smith
         Director of Marketing
         National Research Corporation

National Research Corporation Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,790.19 +13.76 0.08%
S&P 500 1,979.92 -7.13 -0.36%
NASDAQ 4,748.3610 -32.9030 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs